BCAT1 and colorectal carcinoma: A two-markers blood test for methylated BCAT1 and IKZF1 reached a sensitivity of 66% and a specificity of 94% for CRC detection in a prospective study, which enrolled 2107 individuals including 129 CRC patients [13].